Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT07410676

Conditions: Adnexal Diseases, Astrocytoma, Bladder Cancer, +88 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

NCT07410494

Conditions: Acute Myeloid Leukemia (AML), Adenocarcinoma, Adnexal Diseases, +92 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions: Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations: City of Hope National Medical Center Duarte, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Rigshospitalet Copenhagen, Denmark

View all 25 locations

View Trial Details

Recruiting

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

NCT04485013

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +70 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

University of Southern California Los Angeles, California, United States

Hoag Memorial Hospital Newport Beach, California, United States

Rocky Mountain Cancer Centers Denver, Colorado, United States

View all 41 locations

View Trial Details

Recruiting

Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers

NCT07407166

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

NCT04278118

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +33 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630

Conditions: Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
Locations: AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy

University of Perugia Perugia, Italy

View Trial Details

Recruiting

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

NCT04567706

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

NCT05504291

Conditions: Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Eye Diseases, +16 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

View all 20 locations

View Trial Details

Recruiting

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

NCT06151236

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions